Which organizations have issued guidelines for pharmacologic intervention for breast cancer risk reduction?

Updated: Feb 04, 2021
  • Author: Pavani Chalasani, MD, MPH; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print

Guidelines for pharmacologic intervention in women who are at increased risk for breast cancer, but do not have a personal history of breast cancer, have been issued by the American Society of Clinical Oncology (ASCO) [177] and the U.S. Preventive Services Task Force (USPSTF). [178] The guidelines differ in their classification of increased risk and in their inclusion of women with lobular carcinoma in situ (LCIS).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!